A transforming growth factor-β antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury

Journal of Cerebral Blood Flow and Metabolism

Volumn 19, Issue 12, 1999, Pages 1345-1353

  Ruocco, Antonio ^a   Nicole, Olivier ^a   Docagne, Fabian ^a   Ali, Carine ^a   Chazalviel, Laureut ^a   Komesli, Sylviane ^b   Yablonsky, Françoise ^b   Roussel, Simon ^a   MacKenzie, Eric T ^a   Vivien, Deny ^a   Buisson, Alain ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b Laboratoires Fournier SA   (France)

Author keywords

Cytokine; Excitotoxicity; Ischemia; TGF

Indexed keywords

IMMUNOGLOBULIN FC FRAGMENT; N METHYL DEXTRO ASPARTIC ACID; RECEPTOR ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; BRAIN ISCHEMIA; BRAIN TISSUE; FETUS; GENE OVEREXPRESSION; MOUSE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROMODULATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING;

EID: 17544366612     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-199912000-00008     Document Type: Article

References (16)

1. Buisson A, Nicole O, Docagne F, Sartelet H, MacKenzie ET, Vivien D (1998) Up-regulation of a serine-protease inhibitor (PAI-1) in astrocytes mediates the neuroprotective activity of transforming growth factor-β1 (TGF-β1). FASEB J 12:1683-1691.
2. Chao CC, Hu S, Tsang M, Weatherbee J, Molitor TW, Anderson WR, Peterson PK (1992) Effects of transforming growth factor-beta on murine astrocyte glutamine synthetase activity: implications in neuronal injury. Brain Res 760:52-58.
3. Choi DW (1992) Excitotoxic cell death. J Neurobiol 23:261-1276
4. Da Cunha A, Jefferson JJ, Tyor WR, Glass JD, Jannota FS, Viotkovic L (1993) Control of astrocytosis by interleukin-1 and transforming growth factor beta 1 in human brain. Brain Res 631:39-45
5. Del Zoppo GJ, Wagner S and Tagaya M (1997) Trends and future developments in the pharmacological treatment of acute ischaemic stroke. Drugs 54:9-38
6. Dennler S, Susumu I, Vivien D, ten Dijke P, Huet S, Gauthier JM (1998) Direct Binding of Smad3 and Smad4 to critical TGF-β inducible elements in the promoter of human plasminogen activator inhibitor type-1 gene. EMBO J 17:3091-3100
7. Feuerstein GZ, Wang X, Barone FC (1998) The role of cytokines in the neuropathology of stroke and neurotrauma. Neuroimmunomodulation 5:143-59
8. Harpel JG, Metz CN, Kojima S, Rifkin DB (1992) Control of transforming growth factor β activity: latency vs activation. Prog Growth Factor Res 4:321-335
9. Henrich-Noack P, Prehn JH, Krieglstein J (1994) Neuroprotective effects of TGF-β1. J Neural Transm Suppl 43:33-45
10. Inagaki Y, Truter S, and Ramirez F (1994) TGF-β stimulates a2(l) collagen gene expression through a cis acting element that contains an Spl-binding site. J Biol Chem 269:14828-14834
11. Kim J, Johnson K, Chen HJ, Carrol S, Laughon A (1997) Drosophilia Mad binds to DNA and directly mediates activation of vestigial by decapentaplegic peptide. Nature 388:304-308
12. Klempt ND, Sirimanne E, Gunn AJ, Klempt M, Singh K, Williams C, Gluckman PD (1992) Hypoxia-ischemia induces transforming growth factor beta 1 mRNA in the infant rat brain. Brain Res Mol Brain Res 13:93-101
13. Koh JY, Choi DW (1987) Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods 20:83-90
14. Komesli S, Vivien D, Dutartre P (1998) Chimeric extracellular domain of type II transforming growth factor (TGF)-β receptor fused to the Fc region of human immunoglobulin as a TGF-β antagonist. Eur J Biochem 254:505-513
15. Krieglstein K, Krieglstein J (1998). Neuroprotection Signal Transduction (Matson MP, ed), Totowa NJ, Humana Press, pp 119-144
16. Krupinski J, Kumar P, Kumar S, Path FRC, Kaluza J (1996) Increased expression of TGF-βl in brain tissue after ischemic stroke in human. Stroke 27:852-857